Product Name

Trimetazidine dihydrochloride

General description

Trimetazidine dihydrochloride is a kind of drug for treatment of chronic ischemic disorders. It improves myocardial glucose utilization through inhibition of fatty acid metabolism, known as fatty acid oxidation inhibitor.

Synonym

Yoshimilon, Kyurinett, Vastarel F; 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine; dihydrochloride

Purity

≥98.0%(HPLC)

CAS Number

13171-25-0

Formula

C¹⁴H²⁴Cl²N²O³

Molecular Weight

339.257

Suitability

BioReagent, suitable for cell culture, etc.

l  Physical and Chemical Information

Appearance

White Solid

Solubility(25°C)

DMSO

≥50mg/ml

Water

≥50mg/ml

l  Biological Information

Biochem/Physiol  Actions

A vasodilator used in angina of effort or ischemic heart disease.

Application

Vasodilator Agents

l  Storage

Storage temp.

-20°C

l  Precautions and Disclaimer

This product is for R&D use only, not for drug, household, or other uses.

l  References

1.    http://www.drugbank.ca

2.    https://ncit.nci.nih.gov

3.    https://www.ncbi.nlm.nih.gov